Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 43 | 111 | 529 | 1 | 9 |
| Gross Profit | 43 | 111 | 529 | 1 | 9 |
| Operating Expenses | 28,338 | 25,964 | 22,998 | 19,360 | 14,052 |
| Operating Income | -28,295 | -25,853 | -22,469 | -19,359 | -14,043 |
| Other Income | 7,890 | 6,951 | 5,535 | 2,800 | 2,275 |
| Pre-tax Income | -20,405 | -18,902 | -16,934 | -16,559 | -11,768 |
| Net Income Continuous | -20,405 | -18,902 | -16,934 | -16,559 | -11,768 |
| Net Income | $-20,405 | $-18,902 | $-16,934 | $-16,559 | $-11,768 |
| EPS Basic Total Ops | -0.30 | -0.28 | -0.36 | -4.50 | -4.00 |
| EPS Basic Continuous Ops | -0.30 | -0.28 | -0.36 | -3.33 | -2.68 |
| EPS Diluted Total Ops | -0.30 | -0.28 | -0.36 | -4.50 | -4.00 |
| EPS Diluted Continuous Ops | -0.30 | -0.28 | -0.36 | -3.33 | -2.68 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.28 | -0.36 | N/A | N/A |
| EBITDA(a) | $-29,856 | $-28,312 | $-24,664 | $-20,810 | $-15,181 |